RESCAP in severe burn wound trial

Alloksys’s RESCAP platform therapeutic compound will be applied in patients that suffer from severe burn trauma. RESCAP administration is expected to significantly attenuate the overall ischemic clinical condition of these severely burn-patients and thereby improve on recuperation of these patients, primarily during ICU treatment period. The study will be carried out at the Burn Centre, Red Cross Hospital, Beverwijk, The Netherlands, lead by dr P.M. van Zuijlen